نتایج جستجو برای: nitrogen donor ligands

تعداد نتایج: 285320  

Journal: :Dalton transactions 2014
Manuela Delgado-Rebollo Daniel Canseco-Gonzalez Manuela Hollering Helge Mueller-Bunz Martin Albrecht

We report on the synthesis of a variety of C,E-bidentate triazolylidene ruthenium complexes that comprise different donor substituents E (E = C: phenyl anion; E = O: carboxylate, alkoxide; E = N: pyridine at heterocyclic carbon or nitrogen). Introduction of these donor functionalities is greatly facilitated by the synthetic versatility of triazoles, and their facile preparation routes. Five dif...

The interactions between platinum complexes and human serum albumin (HSA) play crucial roles in the distribution, metabolism, and activity of platinum-based anticancer drugs. Octahedral platinum (IV) complexes represent a significant class of anticancer agents that display molecular pharmacological properties different from cisplatin. In this study, the interaction between two Pt(IV) complexes ...

Journal: :Journal of Experimental Nanoscience 2021

By utilizing the mixed-ligand method, two novel metal-organic frameworks (MOFs) based on Zn(II) ions as nodes with chemical formulae of {[Zn2.5(abta)(trz)2(H2O)]·3H2O}n (1, Htrz = 1H-1,2,4-triazole) and [Zn3(abta)2(bibb)2]n (2, bibb 1,4-bis(benzimidazol-1-yl)-2-butene) were produced via Zn(NO3)2·6H2O reacting 1-aminobenzene-3,4,5-tricarboxylic acid (H3abta) in existence distinct nitrogen-donor ...

Journal: :Angewandte Chemie 2022

A systematic study to access stable stannaimines is reported, by combining different heteroleptic stannylenes with a range of organic azides. The reactions terphenyl-/hypersilyl-substituted yield the putative tin nitrogen double bond, but directly followed 1,2-silyl migration give SnII systems featuring bulky silylamido ligands. By contrast, transition from two σ donor ligand set mixed σ-donor/...

ژورنال: یافته 2012
انتظامی, کبری , علی مقدم, کامران, شاهسوار, فرهاد ,

Background : Allogeneic hematopoietic stem cells transplantation (HSCT) is a valuable therapy for refractory acute leukemias, leukemias with a high risk for relapse, myelodysplastic syndromes, and chronic myeloid leukemia. HSCT outcome is dependent on several factors, including the stage of disease, degree of human leukocyte antigen (HLA) identity between donor and recipient, conditioning regim...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید